StockData
Nuvation Bio Inc. logo

Nuvation Bio Inc. (NUVB) stock

NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30107% above fair value
$3.90+0.06 (+1.56%)

Close on Nov 17, 2026Market cap $1.37BP/E –Yield –

Nuvation Bio total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Nuvation Bio's total debt was $5.89M at Jun 30, 2026. For fiscal 2025 it was $5.72M, down 8.9% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.72M-8.9%
FY2024Dec 31, 2024$6.28M–
FY2023Dec 31, 2023$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.89M+5.6%
Q1 FY2026Mar 31, 2026$5.79M+1.8%
Q4 FY2025Dec 31, 2025$5.72M-8.9%
Q3 FY2025Sep 30, 2025$5.62M-33.3%
Q2 FY2025Jun 30, 2025$5.58M-52.0%
Q1 FY2025Mar 31, 2025$5.69M–
Q4 FY2024Dec 31, 2024$6.28M–
Q3 FY2024Sep 30, 2024$8.43M–
Q2 FY2024Jun 30, 2024$11.63M–
Q4 FY2023Dec 31, 2023$0–

More Nuvation Bio figures

See a number that looks wrong?